Symeres is a leading European small molecule CRDMO that has been a trusted global partner for biopharma companies for over 20 years

Symeres is a leading mid-sized European Contract Research Development and Manufacturing Organization (CRDMO) specialised in small molecules. The company offers best-in-class solutions for drug discovery and drug development with services that span from early-stage hit finding all the way to the delivery of early clinical phase active pharmaceutical ingredients (API). Headquartered in the Netherlands, with over 500 scientists, Symeres blends a deep scientific knowledge base with a solutions focused approach to deliver quality results to its biotech and pharma customers located in Europe, North America, and Asia.

Headquarters

NETHERLANDS



Investment Year

2021

Status

CURRENT